Aclacinomycin A

Overview

Aclacinomycin A (Aclarubicin) is an orally active and potent anthracycline antitumor antibiotic . Aclacinomycin A is an inhibitor of topoisomerase I and II . Aclacinomycin A inhibits synthesis of nucleic acid, especially RNA . Aclacinomycin A might inhibit the 26S protease complex as well as the ubiquitin-ATP-dependent proteolysis.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Topoisomerase | Products > Signaling Pathways > DNA/RNA Synthesis | Products > Signaling Pathways > Proteasome | Products > Signaling Pathways > Antibiotic

Product Information

• Catalog No.: HY-N2306
• CAS No.: 57576-44-0
• Molecular Formula: C42H53NO15
• Molecular Weight: 811.87
• Purity: 96.22%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source